| S-2-Chloro-3-phenylpropionic acid |
41998-38-3 |
C9H9O2Cl |
| 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)propan-2-ol hydrochloride |
1441765-57-6 |
C14H22BNO3.HCl |
| B-(1-oxido-4-pyridinyl)-Boronic acid |
859160-66-0 |
C5H6BNO3 |
| 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-Pyridinecarboxylic acid ethyl ester |
741709-57-9 |
C14H20BNO4 |
| B-[6-(dimethylamino)-4-ethyl-3-pyridinyl]-Boronic acid hydrochloride |
848360-83-8 |
C9H15BN2O2.HCl |
| B-[6-(dimethylamino)-2-methyl-3-pyridinyl]-Boronic acid |
910054-74-9 |
C8H13BN2O2 |
| pyridin-2-amine 1-oxide monohydrochloride |
57097-28-6 |
C5H6N2O.ClH |
| 2,3,5,6-tetrabromo-para-xylene |
23488-38-2 |
C8H6Br4 |
| 7-bromo-4,4-dimethyl-1-tetralone |
166978-46-7 |
C12H13OBr |
| 2-(phenylmethyl)-Imidazo[1,2-a]pyridine |
889813-26-7 |
C14H12N2 |
| 1,6-dihydro-6-oxo-9H-Purine-9-acetic acid |
6298-53-9 |
C7H6N4O3 |
| 2-(2-methyl-1H-imidazol-1-yl)-1H-Indole |
1225068-06-3 |
C12H11N3 |
| Imidazo[1,5-a]pyrazine-1-carboxylic acid ethyl ester |
1377584-27-4 |
C9H9N3O2 |
| 1-((2-Hydroxy-1-methyl)ethyl)-2-methyl-5-nitroimidazole |
56750-04-0 |
C7H11N3O3 |
| 1-[(4-ethenylphenyl)methyl]-1H-Imidazole |
78430-91-8 |
C12H12N2 |
| 9-(2-propen-1-yl)-9H-Purin-6-amine |
4121-39-5 |
C8H9N5 |
| 2-chloro-7-methyl-7H-Purine |
55286-05-0 |
C6H5N4Cl |
| 5,6,7,8-tetrahydro-Imidazo[1,2-a]pyridine-2-methanol |
1038827-92-7 |
C8H12N2O |
| 4-methyl-1H-Imidazo[4,5-d]pyridazin-7-amine |
813462-82-7 |
C6H7N5 |
| 1,3-dihydro-5-methyl-1-(2-propen-1-yl)-2H-Imidazol-2-one |
13870-63-8 |
C7H10N2O |
| a,a-dimethyl-1H-Imidazole-2-methanol |
36365-23-8 |
C6H9N2O |
| 1-methyl-1H-Imidazole-4-ethanol |
58177-25-6 |
C6H10N2O |
| 1-methyl-1H-imidazol-4-amine |
89088-69-7 |
C4H7N3.HCl |
| 5-methoxy-1H-Imidazole |
88945-43-1 |
C4H6N2O |
| N-Butyl cyanoacetate |
5459-58-5 |
C7H11NO2 |
| 4-Chloro-2-fluoro-3-methoxyphenylboronic acid |
944129-07-1 |
C7H7BO3FCl |
| 2-Iodo-9,9-dimethylfluorene |
144981-85-1 |
C15H13I |
| 2-Hydroxy-5-bromopyridine |
13466-38-1 |
C5H4NOBr |
| 2,3-Difluoro-4-methoxyphenylboronic acid |
170981-41-6 |
C7H7BO3F2 |
| 2,3-Difluoro-4-ethoxyphenylboronic acid |
212386-71-5 |
C8H9BO3F2 |
| 1-Bromo-4-ethoxy-2,3-difluorobenzene |
156573-09-0 |
C8H7OF2Br |
| N-octanoyl benzotriazole |
58068-80-7 |
C14H19N3O |
| Cyclohexanecarboxaldehyde |
2043-61-0 |
C7H12O |
| 9,9-Dimethylfluorene |
4569-45-3 |
C15H14 |
| 4-Phenoxybenzeneboronic acid |
51067-38-0 |
C12H11BO3 |
| 4-Methoxy-2,3-difluorophenol |
261763-29-5 |
C7H6O2F2 |
| 4-Ethoxy-2,3-difluorophenol |
126163-56-2 |
C8H8F2O2 |
| 3,4,5-Trifluorophenyl boronic acid |
143418-49-9 |
C6H4BF3O2 |
| 2-Octyl cyanoacetate |
52688-08-1 |
C11H19NO2 |
| 2,3-Difluoro-1-ethoxybenzene |
121219-07-6 |
C8H8OF2 |
| 1-Propoxy-2,3-difluorobenzene |
124728-93-4 |
C9H10OF2 |
| 2,3-difluoro-1-butoxybenzene |
136239-66-2 |
C10H12OF2 |
| 3-(tert-Butoxycarbonyl)phenylboronic acid |
220210-56-0 |
C11H15BO4 |
| 2,3-Difluoroanisole |
134364-69-5 |
C7H6OF2 |
| 2-(Trifluoromethyl)benzyl bromide |
395-44-8 |
C8H6F3Br |
| 5-Bromo-2-chloropyridine |
53939-30-3 |
C5H3NClBr |
| 2,3-DifluoroBrmorobenzene |
38573-88-5 |
C6H3F2Br |
| 2-Chloro-5-nitropyridine |
4548-45-2 |
C5H3N2O2Cl |
| 4-Bromo-2,6-difluorobenzoic acid |
183065-68-1 |
C7H3O2F2Br |
| 2,3-Difluorophenol |
6418-38-8 |
C6H4OF2 |
| 3-Carboxyphenylboronic acid |
25487-66-5 |
C7H7BO4 |
| 4-Bromobenzenamine |
106-40-1 |
|
| 5-Fluoro-2-methoxy-4(1H)pyrimidinone |
1480-96-2 |
C5H5N2O2F |
| 2-Iodo-5-phenylpyridine |
120281-56-3 |
C11H8Ni |
| [4-(2,2,2-Trifluoroethoxy)phenyl]boronic acid |
886536-37-4 |
C8H8BO3F3 |
| 3,4-Dimethoxyphenethylamine |
120-20-7 |
C10H15NO2 |
| Tolyltriazole |
29385-43-1 |
C9H9N3 |
| 1,4,5,8-Tetrathiafulvalen |
31366-25-3 |
C6H4S4 |
| Etanercept |
185243-69-0 |
|
| Alemtuzumab |
216503-57-0 |
|
| Mepolizumab |
196078-29-2 |
C42H66O12 |
| Panitumumab |
339177-26-3 |
|
| Pertuzumab |
380610-27-5 |
|
| Natalizumab |
189261-10-7 |
|
| Tocilizumab |
375823-41-9 |
|
| Dulaglutide |
923950-08-7 |
|
| Atezolizumab |
1380723-44-3 |
|
| Daratumumab |
945721-28-8 |
|
| Secukinumab |
1229022-83-6 |
|
| Ramucirumab |
947687-13-0 |
|
| Omalizumab |
242138-07-4 |
|
| Ustekinumab |
815610-63-0 |
C14H18N5O2Cl3 |
| Eculizumab |
219685-50-4 |
|
| Alirocumab |
1245916-14-6 |
|
| Evolocumab |
1256937-27-5 |
|
| Denosumab |
615258-40-7 |
|
| Vedolizumab |
943609-66-3 |
|
| Ipilimumab |
477202-00-9 |
|
| Bevacizumab |
216974-75-3 |
|
| Infliximab |
170277-31-3 |
|
| Adalimumab |
331731-18-1 |
C6428H9912N1694O1987S46 |
| Cetuximab |
205923-56-4 |
C33H38N4O6.C20H23N7O7.C4H3N2O2F |
| Aflibercept |
845771-78-0 |
|
| Nivolumab |
946414-94-4 |
|
| Glycine |
56-40-6 |
C2H5NO2 |
| 2-Methoxyethylamine |
109-85-3 |
C3H9NO |
| Estriol |
50-27-1 |
C18H24O3 |
| Ibutamoren-mesylate |
159752-10-0 |
C28H40N4O8S2 |
| All trans-Retinal |
116-31-4 |
C20H28O |
| 2,2'-([1,1'-biphenyl]-4,4'-diyldivinylene)bis(benzenesulphonic) acid |
38775-22-3 |
C28H22O6S2 |
| Triarylsulfonium Hexafluoroantimonate Salts in Propylene Carbonate |
109037-75-4 |
C36H28S3+2.C24H19S2+.3[F6Sb-] |
| 2-Amino-3,5-dibromopyrazine |
24241-18-7 |
C4H3N3Br2 |
| 2,4(1H,3H)-Pyrimidinedione, 5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]- |
183204-74-2 |
C9H11ClN4O2 |
| 2,4(1H,3H)-Pyrimidinedione,5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-, hydrochloride (1:1) |
183204-72-0 |
C9H12Cl2N4O2 |
| Cyclohex-2-enol |
822-67-3 |
C6H10O |
| 5-Phenoxyisobenzofuran-1(3H)-one |
57830-14-5 |
C14H10O3 |
| 2-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid |
808118-40-3 |
C19H16N2O5 |
| Urolithin M7 |
531512-26-2 |
C13H8O5 |
| Urolithin M6 |
1006683-97-1 |
C13H8O6 |
| Urolithin D |
131086-98-1 |
C13H8O6 |
